Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial
Brief description of study
If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.
Detailed description of study
What is the medication that is being tested?
The study medication is an antiviral pill that is designed to reduce symptoms of COVID-19
Is there payment for taking part in this study?
Participants who complete all expected parts of the study will earn $500
Am I eligible to join this study?
To find out and to learn more, please fill out the screening form below
__________________________________________________________
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
COVID-19
-
Age: Between 18 Years - 64 Years
-
Gender: All
Updated on
09 Mar 2024.
Study ID: 851173
Pre-Screener
